The U.S. Food and Drug Administration (FDA) and Boston Scientific today sent an urgent alert to patients and healthcare providers about the…

While the technology and techniques associated with transcatheter aortic valve replacement (TAVR) have advanced over the years, treating patients who…

The diagnosis and management of clinically suspected acute myocarditis is an important topic for clinicians from a variety of backgrounds, including cardiologists, primary care physicians, emergency physicians and rheumatologists.

According…

The U.S. Senate has unanimously passed the HEARTS Act, HR.6829, a bipartisan bill designed to improve cardiomyopathy education and awareness while getting more…

Acutus Medical, the California-based healthcare technology company focused on electrophysiology devices, has announced…

AOP Health, an Austrian pharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for landiolol to be used in a critical care setting for the treatment of supraventricular tachycardia…

Left atrial appendage closure (LAAC) with Boston Scientific’s…

Eko Health has received a new Category III CPT code from the American Medical Association (AMA) for its Sensora platform, ensuring its use can be properly documented by coding specialists whenever necessary…

It may be impossible to accurately predict when heart attack survivors are going to experience sudden cardiac death later in life, according to a new analysis published in European Heart Journal.[1] That could change in the future, of…

Treating atrial fibrillation (AFib) during cardiac surgeries with concomitant surgical ablation (SA) is associated with better long-term patient outcomes, according to a new meta-analysis published in the American Journal of Cardiology.[…

Johnson & Johnson MedTech has received U.S. Food and Drug Administration (FDA) approval for its Varipulse pulsed field ablation (PFA) system designed to treat paroxysmal atrial fibrillation (AFib). The…

Boston Scientific has agreed to acquire Cortex, a healthcare technology company launched by the venture capital firm Ajax Health in 2023, to expand its electrophysiology (…

The Heart Rhythm Society (HRS) has established a new advocacy group dedicated to lobbying for causes important to both electrophysiologists and the heart patients they treat on a daily basis. 

…

Medtronic has received U.S. Food and Drug Administration (FDA) approval for its new Affera mapping and ablation system with the Sphere-9 catheter, an all-in-one electrophysiology offering capable of pulsed field…

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Farawave Nav ablation…

Cardiac arrhythmias are common in patients with COVID-19 infections and during recovery, which prompted a new scientific statement from the…

Cardiologists have performed what they believe to be the world’s first substernal lead extraction, sharing their experience in JACC: Case Reports.[1]

The care team, working out of the Regional University Hospital Center of Tours in…

Medtronic’s OmniaSecure defibrillation lead, already associated with positive early outcomes, is projected to deliver long-term durability, according to a new analysis published in HeartRhythm.[1]

The device, which Medtronic…

Patient care in the United States has never been more advanced than it is today, with artificial intelligence and other emerging technologies evolving at a remarkable…

The Heart Rhythm Society (HRS) has shared a new statement emphasizing the importance of atrial fibrillation (AFib) ablation procedures being performed by trained electrophysiologists (EPs).

These…

Focal pulsed field ablation (PFA) is a safe, effective treatment option for premature ventricular contractions (PVC), according to new data published in Circulation: Arrhythmia and Electrophysiology.[1]

“Limited evidence on PFA-…